(Q41108275)

English

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study).

scientific article published on 14 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

based on heuristic

inferred from title

Stefano Rusconi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

S Bonora

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

A Calcagno

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

M Bracchi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

O Viganò

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

M Lanzafame

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

A Trentalange

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

L Marinaro

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

A D'Avolio

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

G Di Perri

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

0 references

publication date

14 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

70

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

3096-3099

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudine.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Factors predictive of virological failure on atazanavir in 310 HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV208

21 January 2018

Identifiers

10.1093/JAC/DKV208

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

release_ffnawkvjzbdt5dv25mlvus6ezm

1 reference

https://api.fatcat.wiki/v0/release/ffnawkvjzbdt5dv25mlvus6ezm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26174719%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41108275&oldid=2094013719"